
Pliant Therapeutics, Inc.
PLRXHealthcare|Biotechnology|US
$0.81
-0.01 (-0.75%)
DCF Value
$0.27
Tangible Book / Share
$2.37
Cash / Share
$2.55
Ownership Breakdown
88.9%
Float
61.9M
Shares Outstanding
55.0M
Float Shares
Major Holders (28)
Combined: 94.6%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Tang Capital Management, LLC | Other | 9.60% | 5,859,044 | Mar 10, 2025 | 13D/G |
| Kevin Tang | Individual | 9.60% | 5,859,044 | Mar 10, 2025 | 13D/G |
| Daniel Schneeberger | HC, IN | 8.90% | 5,509,724 | Aug 14, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 8.90% | 5,509,724 | Aug 14, 2026 | 13D/G |
| Tang Capital Partners, LP | Partnership | 5.40% | 3,295,127 | Mar 10, 2025 | 13D/G |
| Blue Owl Capital Holdings LP | Partnership | 4.94% | 3,004,199 | Nov 14, 2024 | 13D/G |
| The Vanguard Group | Investment adviser | 4.89% | 3,002,348 | Jul 29, 2025 | 13D/G |
| Jeremy C. Green | HC, IN | 4.80% | 2,895,478 | Feb 14, 2025 | 13D/G |
| Redmile Group, LLC | IA, OO | 4.80% | 2,895,478 | Feb 14, 2025 | 13D/G |
| Tang Capital Partners International, LP | Partnership | 4.20% | 2,563,917 | Mar 10, 2025 | 13D/G |
| Kenneth Griffin | HC, IN | 3.50% | 2,143,426 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 3.40% | 2,104,574 | Jul 17, 2025 | 13D/G |
| Woodline Partners LP | IA, PN | 3.30% | 2,026,191 | Feb 17, 2026 | 13D/G |
| Mathew P. Arens | Individual | 3.21% | 1,951,467 | Nov 14, 2024 | 13D/G |
| First Light Asset Management, LLC | Investment adviser | 3.08% | 1,875,467 | Nov 14, 2024 | 13D/G |
| Citadel GP LLC | HC, OO | 2.30% | 1,418,022 | Aug 14, 2026 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 2.30% | 1,418,022 | Aug 14, 2026 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 2.30% | 1,418,022 | Aug 14, 2026 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 1.20% | 725,404 | Aug 14, 2026 | 13D/G |
| Citadel Securities Group LP | HC, PN | 1.20% | 725,404 | Aug 14, 2026 | 13D/G |
| Citadel Securities LLC | BD, OO | 1.10% | 673,114 | Aug 14, 2026 | 13D/G |
| Morgan Stanley | HC, CO | 0.90% | 545,228 | Jan 8, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 0.20% | 131,993 | Mar 7, 2025 | 13D/G |
| FMR LLC | Holding company | 0.20% | 131,993 | Mar 7, 2025 | 13D/G |
| Point72 Capital Advisors, Inc. | Corporation | 0.10% | 46,537 | Feb 17, 2026 | 13D/G |
| Steven A. Cohen | Individual | 0.10% | 46,537 | Feb 17, 2026 | 13D/G |
| Point72 Asset Management, L.P. | Partnership | 0.10% | 46,537 | Feb 17, 2026 | 13D/G |
| T. Rowe Price Associates, Inc. | Investment adviser | 0.10% | 87,674 | May 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 6,361,148 acquired · 3,143,976 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Raben David | Chief Medical Officer | Oct 1, 2026 | AWARD | 575,000 | $1.05 | $603.8K | Form 4 |
| Raben David | officer | Sep 30, 2026 | OTHER | 0 | — | — | Form 4 |
| Iannone Robert | director: | Jul 9, 2026 | OTHER | 0 | — | — | Form 4 |
| Iannone Robert | director | Jul 9, 2026 | AWARD | 60,000 | $1.13 | $67.8K | Form 4 |
| Borellini Flavia | director: | Jul 9, 2026 | OTHER | 0 | — | — | Form 4 |
| Borellini Flavia | director | Jul 9, 2026 | AWARD | 60,000 | $1.13 | $67.8K | Form 4 |
| CROWELL GAYLE A | director | Jun 11, 2026 | AWARD | 70,000 | $1.14 | $79.8K | Form 4 |
| MCCOURT Thomas A | director | Jun 11, 2026 | AWARD | 70,000 | $1.14 | $79.8K | Form 4 |
| Krognes Steve E. | director | Jun 11, 2026 | AWARD | 70,000 | $1.14 | $79.8K | Form 4 |
| Curnutte John T | director | Jun 11, 2026 | AWARD | 70,000 | $1.14 | $79.8K | Form 4 |
| Huh Hoyoung | director | Jun 11, 2026 | AWARD | 70,000 | $1.14 | $79.8K | Form 4 |
| Cline Darren S | director | Jun 11, 2026 | AWARD | 70,000 | $1.14 | $79.8K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Apr 17, 2026 | AWARD | 150,000 | $1.33 | $199.5K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Apr 17, 2026 | AWARD | 55,200 | $1.33 | $73.4K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Apr 17, 2026 | AWARD | 40,000 | $1.33 | $53.2K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Apr 17, 2026 | DISPOSED | 55,200 | $11.14 | $614.9K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Apr 17, 2026 | DISPOSED | 150,000 | $16.18 | $2.4M | Form 4 |
| Kuo Minnie | Chief Operating Officer | Apr 17, 2026 | DISPOSED | 40,000 | $17.44 | $697.6K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 124,000 | $1.33 | $164.9K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 113,300 | $1.33 | $150.7K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 110,500 | $1.33 | $147.0K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 76,200 | $1.33 | $101.3K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 76,047 | $1.33 | $101.1K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 74,250 | $1.33 | $98.8K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | AWARD | 18,198 | $1.33 | $24.2K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 113,300 | $11.14 | $1.3M | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 18,198 | $6.22 | $113.2K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 76,047 | $2.08 | $158.2K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 74,250 | $26.50 | $2.0M | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 124,000 | $11.86 | $1.5M | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 76,200 | $34.65 | $2.6M | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Apr 17, 2026 | DISPOSED | 110,500 | $17.44 | $1.9M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 440,000 | $1.33 | $585.2K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 327,262 | $1.33 | $435.3K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 325,000 | $1.33 | $432.3K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 256,300 | $1.33 | $340.9K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 250,000 | $1.33 | $332.5K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 206,300 | $1.33 | $274.4K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | AWARD | 146,841 | $1.33 | $195.3K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 146,841 | $2.08 | $305.4K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 327,262 | $6.22 | $2.0M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 250,000 | $26.50 | $6.6M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 440,000 | $11.86 | $5.2M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 206,300 | $34.65 | $7.1M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 256,300 | $17.44 | $4.5M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Apr 17, 2026 | DISPOSED | 325,000 | $11.14 | $3.6M | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Apr 17, 2026 | AWARD | 123,000 | $1.33 | $163.6K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Apr 17, 2026 | AWARD | 52,000 | $1.33 | $69.2K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Apr 17, 2026 | AWARD | 51,750 | $1.33 | $68.8K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Apr 17, 2026 | DISPOSED | 52,000 | $17.44 | $906.9K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Apr 17, 2026 | DISPOSED | 123,000 | $21.93 | $2.7M | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Apr 17, 2026 | DISPOSED | 51,750 | $11.14 | $576.5K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 22, 2026 | AWARD | 400,000 | $1.30 | $520.0K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Jan 22, 2026 | AWARD | 300,000 | $1.30 | $390.0K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Jan 22, 2026 | AWARD | 300,000 | $1.30 | $390.0K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Jan 22, 2026 | AWARD | 1,230,000 | $1.30 | $1.6M | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 20, 2026 | SELL | 24,002 | $1.28 | $30.7K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Jan 20, 2026 | SELL | 7,534 | $1.28 | $9.6K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Jan 20, 2026 | SELL | 89,375 | $1.28 | $114.4K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Jan 20, 2026 | SELL | 6,917 | $1.28 | $8.9K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Dec 10, 2025 | OTHER | 0 | — | — | Form 4 |
| Kuo Minnie | Chief Operating Officer | Dec 10, 2025 | OTHER | 150,000 | $16.18 | $2.4M | Form 4 |
| Kuo Minnie | Chief Operating Officer | Dec 10, 2025 | OTHER | 40,000 | $17.44 | $697.6K | Form 4 |
| Kuo Minnie | Chief Operating Officer | Dec 10, 2025 | OTHER | 55,200 | $11.14 | $614.9K | Form 4 |
| Bruhn Suzanne Louise | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| Knobil Katharine | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| MCCOURT Thomas A | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| Curnutte John T | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| Krognes Steve E. | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| Cline Darren S | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| PYOTT DAVID E I | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| Huh Hoyoung | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| CROWELL GAYLE A | director | Jun 5, 2025 | AWARD | 30,000 | $1.61 | $48.3K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Jan 23, 2025 | AWARD | 51,750 | $11.14 | $576.5K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Jan 23, 2025 | AWARD | 25,875 | — | — | Form 4 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 23, 2025 | AWARD | 35,000 | — | — | Form 4 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 23, 2025 | AWARD | 70,000 | $11.14 | $779.8K | Form 4 |
| Hull Hans | Chief Business Officer | Jan 23, 2025 | AWARD | 40,150 | — | — | Form 4 |
| Hull Hans | Chief Business Officer | Jan 23, 2025 | AWARD | 80,300 | $11.14 | $894.5K | Form 4 |
| Lefebvre Eric | Chief Medical Officer | Jan 23, 2025 | AWARD | 45,650 | — | — | Form 4 |
| Lefebvre Eric | Chief Medical Officer | Jan 23, 2025 | AWARD | 91,300 | $11.14 | $1.0M | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 23, 2025 | AWARD | 56,650 | — | — | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 23, 2025 | AWARD | 113,300 | $11.14 | $1.3M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Jan 23, 2025 | AWARD | 162,500 | — | — | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Jan 23, 2025 | AWARD | 325,000 | $11.14 | $3.6M | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Jan 17, 2025 | SELL | 52,419 | $11.20 | $587.2K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 17, 2025 | SELL | 20,148 | $11.20 | $225.7K | Form 4 |
| Hull Hans | Chief Business Officer | Jan 17, 2025 | SELL | 15,936 | $11.20 | $178.5K | Form 4 |
| Lefebvre Eric | Chief Medical Officer | Jan 17, 2025 | SELL | 18,478 | $11.20 | $207.0K | Form 4 |
| Cheung Lily | Chief Human Resource Officer | Jan 17, 2025 | SELL | 3,740 | $11.20 | $41.9K | Form 4 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 17, 2025 | SELL | 13,270 | $11.20 | $148.6K | Form 4 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 22, 2025 | SELL | 10,230 | $10.99 | $112.5K | Form 4 |
| Lefebvre Eric | Chief Medical Officer | Jul 10, 2024 | SELL | 12,319 | $11.56 | $142.4K | Form 4 |
| Hull Hans | Chief Business Officer | Jul 10, 2024 | SELL | 9,900 | $11.56 | $114.4K | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jul 10, 2024 | SELL | 10,911 | $11.56 | $126.1K | Form 4 |
| Coulie Bernard | director, officer: President and CEO | Jul 10, 2024 | SELL | 38,710 | $11.56 | $447.5K | Form 4 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jul 10, 2024 | SELL | 7,656 | $11.56 | $88.5K | Form 4 |
| Lefebvre Eric | Chief Medical Officer | Jul 9, 2024 | AWARD | 24,063 | — | — | Form 4 |
| Hull Hans | Chief Business Officer | Jul 9, 2024 | AWARD | 19,337 | — | — | Form 4 |
| Cummings Keith Lamont | Chief Financial Officer | Jul 9, 2024 | AWARD | 21,313 | — | — | Form 4 |